Personalised medicine in Brazil : IP and regulatory challenges

By: Ribeiro, Anderson
Contributor(s): Kashiwabara, Priscila | Ferreira, Aline
Publisher: 2021ISBN: 9781838626082Subject(s): Genes -- Brazil | Research and development -- Biotechnology industry -- Brazil | Patenting of life forms -- BrazilGenre/Form: Book chapter Local URL: SNIPER Full Text In: IAM Life Sciences 2021 2021, pp. 53-57
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)

SNIPER Book Chapter

With the development of techniques such as CRISPR and increasing knowledge in the 'omics', science can now provide what only a few years ago looked like science fiction: personalised medicine (sometimes referred to as 'precision medicine' or 'personalised healthcare'). Personalised medicine is an evolving field where a therapeutic treatment is tailored to an individual with a particular disease and is capable not only of avoiding or minimising harmful side effects caused by mass medicines and treatments (as well as ensuring a more successful outcome), but also helping reduce costs compared with a trial-and-error approach to disease treatment. This chapter aims to discuss the current status of personalised medicine in Brazil from both a regulatory and an IP standpoint, as well as to underline the main challenges in this area.

Creative Commons Attribution 4.0 International (CC BY 4.0)

Item type Current library Call number Status Date due Barcode Item holds
SNIPER IP Australia Library
SNIPER Articles
2021/00682 (Browse shelf (Opens below)) Available 200802890
Total holds: 0

There are no comments on this title.

to post a comment.

Hosted by Prosentient